Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Beatrice, Bussi"'
Autor:
Beatrice Bussi, Marcello Ceccaroni, Ignacio Zapardiel, Begoña Díaz de la Noval, Javier De Santiago, Maria Luisa Gasparri, Michael D. Mueller, Sara Imboden, Francesca Vecchione, Elena De Ponti, Federica Elisei, Alessandro Buda, Andrea Papadia, Fabio Ghezzi, Giampaolo Di Martino, Federica Dell'Orto
Publikováno v:
Papadia, Andrea; Zapardiel, Ignacio; Bussi, Beatrice; Ghezzi, Fabio; Ceccaroni, Marcello; De Ponti, Elena; Elisei, Federica; Imboden, Sara; de la Noval, Begoña Diaz; Gasparri, Maria Luisa; Di Martino, Giampaolo; De Santiago, Javier; Mueller, Michael; Vecchione, Francesca; Dell'Orto, Federica; Buda, Alessandro (2017). Sentinel lymph node mapping in patients with stage I endometrial carcinoma: a focus on bilateral mapping identification by comparing radiotracer Tc99(m) with blue dye versus indocyanine green fluorescent dye. Journal of cancer research and clinical oncology, 143(3), pp. 475-480. Springer 10.1007/s00432-016-2297-y
PURPOSE The aim of this study was to compare technetium radiocolloid (Tc99(m)) + blue dye (BD) versus Indocyanine green (ICG) fluorescent dye in terms of the overall detection rate and bilateral sentinel lymph node (SLN) mapping in patients with endo
Autor:
Sharon Palazzi, Paolo Di Lorenzo, Rodolfo Milani, Tommaso Grassi, Alessandro Buda, Giampaolo Di Martino, Beatrice Bussi
Publikováno v:
Journal of Minimally Invasive Gynecology. 23:265-269
Indocyanine green (ICG) represents a feasible alternative to the more traditional methods of sentinel lymph node (SLN) mapping, and interest in this promising tracer is growing. This report outlines our experience with ICG in a minimally invasive lap
Autor:
Maria Luisa Gasparri, Debora Verri, Andrea Papadia, Michael D. Mueller, Alessandro Buda, Giampaolo Di Martino, Beatrice Bussi
Publikováno v:
Papadia, Andrea; Buda, Alessandro; Gasparri, Maria Luisa; Di Martino, Giampaolo; Bussi, Beatrice; Verri, Debora; Mueller, Michael (2018). The impact of different doses of indocyanine green on the sentinel lymph-node mapping in early stage endometrial cancer. Journal of cancer research and clinical oncology, 144(11), pp. 2187-2191. Springer 10.1007/s00432-018-2716-3
INTRODUCTION Aim of the study is to evaluate the impact of different doses of indocyanine green (ICG) on the sentinel lymph-node (SLN) mapping in endometrial cancer (EC). MATERIALS AND METHODS A retrospective analysis of EC patients undergoing a lapa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46d8deb32c2379909a4eab291e8adb70
https://boris.unibe.ch/125822/1/30043278.pdf
https://boris.unibe.ch/125822/1/30043278.pdf
Optimizing Strategies for Sentinel Lymph Node Mapping in Early-Stage Cervical and Endometrial Cancer
Autor:
Tiziana Dell'Anna, Alessandro Buda, Martina Delle Marchette, Giampaolo Di Martino, Sharon Palazzi, Beatrice Bussi, Maria Grazia Cantù, Francesca Vecchione, Rodolfo Milani
Publikováno v:
International Journal of Gynecological Cancer. 25:1513-1518
Objective This retrospective study aimed to compare the sentinel lymph node (SLN) mapping results of methylene blue (MB) and indocyanine green (ICG) in women with early-stage endometrial or cervical cancer. Methods From August 2011 to March 2015, all
Autor:
Ignacio Zapardiel, Cinzia Crivellaro, Paolo Di Lorenzo, Federica Elisei, Andrea Papadia, Enrico Vizza, Michael D. Mueller, Beatrice Bussi, Giampaolo Di Martino, Luca Locatelli, Maria Dolores Diestro, Alessandro Buda, Maria Luisa Gasparri, Elena De Ponti
Study Objective To compare sentinel lymph node (SLN) mapping in women with cervical cancer stage >IB1 (tumor size >2 cm) using indocyanine green (ICG) versus the standard technique using radioisotope technetium 99m radiocolloid (Tc99 m ) radiotracer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97bd510d492214c57cbe2231d5473e93
Autor:
Andrea, Papadia, Ignacio, Zapardiel, Beatrice, Bussi, Fabio, Ghezzi, Marcello, Ceccaroni, Elena, De Ponti, Federica, Elisei, Sara, Imboden, Begoña Diaz, de la Noval, Maria Luisa, Gasparri, Giampaolo, Di Martino, Javier, De Santiago, Michael, Mueller, Francesca, Vecchione, Federica, Dell'Orto, Alessandro, Buda
Publikováno v:
Journal of cancer research and clinical oncology. 143(3)
The aim of this study was to compare technetium radiocolloid (Tc99Patients from five European centers with apparently confined clinical stage I endometrial cancer were reviewed. A comparison was made between women who received SLN mapping with pelvic
Autor:
Paolo Passoni, Alessandro Buda, Sonia Magni, Enrico Vizza, Giacomo Corrado, Beatrice Bussi, Giuseppe Cutillo
Publikováno v:
Journal of minimally invasive gynecology. 24(1)
Sentinel lymph node (SLN) mapping has increased its feasibility in both early-stage cervical and endometrial cancer. There are few SLN studies regarding the ovary because of the risk of tumor dissemination and perhaps because the ovary represents an
Autor:
Sharon Palazzi, Cinzia Crivellaro, Francesca Vecchione, Marco Cuzzocrea, Beatrice Bussi, Federica Elisei, Daniela Giuliani, Maurizio Arosio, Elena De Ponti, Giampaolo Di Martino, Tiziana Dell'Anna, Alessandro Buda
Objectives: The purpose of this study was to assess the quality of care in patients who underwent sentinel lymph node (SLN) mapping for endometrial and cervical cancer staging, and evaluate the impact of different techniques on patient satisfaction,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1638b31668bbcd8a61e64bf4055cc0c3
http://hdl.handle.net/10281/127853
http://hdl.handle.net/10281/127853
Autor:
Michael D. Mueller, Beatrice Bussi, Alessandro Buda, Maria Luisa Gasparri, Andrea Papadia, Giampaolo Di Martino, Debora Verri
Publikováno v:
Papadia, Andrea; Buda, Alessandro; Gasparri, Maria Luisa; Di Martino, Giampaolo; Bussi, Beatrice; Verri, Debora; Mueller, Michael (2018). Correction to: The impact of different doses of indocyanine green on the sentinel lymph-node mapping in early stage endometrial cancer. Journal of cancer research and clinical oncology, 144(11), p. 2193. Springer 10.1007/s00432-018-2741-2
Unfortunately, the P value at multivariate analysis for ICG concentration in Table 3 was incorrectly published.
Autor:
Dan-Arin Silasi, Masoud Azodi, Elena Bonazzoli, Alessandro D. Santin, Federica Predolini, Beatrice Bussi, Emiliano Cocco, Salvatore Lopez, Jonathan Black, Diana P. English, Thomas J. Rutherford, Peter E. Schwartz, Carlton L. Schwab, Stefania Bellone, Elena Ratner, Francesca Ferrari
Carcinosarcoma is a deadly gynecologic malignancy with few effective treatment options. The study of new therapies is difficult because of its rarity. The objective of this study was to determine the efficacy of neratinib in the treatment of HER2 amp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b73bc1d62b6ef6432d2a65fa0f6bc1b
https://europepmc.org/articles/PMC4587290/
https://europepmc.org/articles/PMC4587290/